Jung Min Lee Selected Research

Neoplasms (Cancer)

1/2022	Impact of surgery on survival outcomes for Bismuth type IV Klatskin tumors.
9/2021	A modified endoscopic full thickness resection for gastric subepithelial tumors from muscularis propria layer: Novel method.
8/2021	Conversion surgery for initially unresectable extrahepatic biliary tract cancer.
11/2020	UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis.
4/2019	When CAR Meets Stem Cells.
6/2017	Percutaneous Palliative Surgery for Femoral Neck Metastasis Using Hollow Perforated Screw Fixation and Bone Cement.
3/2016	Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
1/2016	Synthesis and biological evaluation of 1,2-dithiol-3-thiones and pyrrolo[1,2-a]pyrazines as novel hypoxia inducible factor-1 (HIF-1) inhibitor.
2/2015	Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents.
1/2015	Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung Min Lee Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 05/2003
9	Infections 01/2022 - 02/2005
7	Chronic Hepatitis B 05/2012 - 06/2006
6	Fibrosis (Cirrhosis) 12/2021 - 08/2010
5	Wounds and Injuries (Trauma) 01/2020 - 07/2014
5	Neoplasm Metastasis (Metastasis) 06/2017 - 07/2009
5	Inflammation (Inflammations) 01/2016 - 11/2004
4	Hemorrhage 02/2022 - 01/2003
4	Breast Neoplasms (Breast Cancer) 11/2020 - 10/2008
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 02/2005
3	Disease Progression 05/2021 - 05/2012
3	Pain (Aches) 03/2019 - 01/2017
3	Burns 06/2016 - 04/2015
3	Hepatocellular Carcinoma (Hepatoma) 03/2016 - 01/2014
3	Hypoxia (Hypoxemia) 01/2016 - 02/2012
2	Hyperplasia 03/2022 - 01/2021
2	Liver Diseases (Liver Disease) 01/2022 - 08/2011
2	Pathologic Constriction (Stenosis) 10/2021 - 01/2016
2	Hypotension (Low Blood Pressure) 11/2019 - 06/2013
2	Myoclonus (Nocturnal Myoclonus) 11/2019 - 05/2018
2	Blepharitis 10/2018 - 01/2016
2	Ascites 03/2016 - 09/2009
2	Hepatitis B 08/2012 - 01/2011
2	Hypertension (High Blood Pressure) 08/2011 - 06/2011
2	Type 2 Diabetes Mellitus (MODY) 08/2011 - 06/2011
2	Septic Shock (Toxic Shock Syndrome) 06/2008 - 02/2008
2	Asthma (Bronchial Asthma) 02/2005 - 11/2004
1	Foreign Bodies (Foreign Body) 02/2022
1	Foreign-Body Reaction 02/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Splenomegaly 01/2022
1	Margins of Excision 01/2022
1	Gastroesophageal Reflux (GERD) 10/2021
1	Esophagitis 10/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/2021
1	Lymphoma (Lymphomas) 06/2021
1	Adenocarcinoma 06/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2021
1	Lymphocytosis 01/2021
1	Hypersensitivity (Allergy) 01/2021

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 08/2007
5	Fibroins (Fibroin)IBA 01/2018 - 07/2014
5	Hepatitis B e AntigensIBA 08/2012 - 06/2006
5	Lamivudine (Epivir)FDA Link 08/2012 - 01/2009
4	CytokinesIBA 01/2022 - 02/2005
4	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 08/2010
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 02/2008
3	adefovirIBA 08/2012 - 01/2009
3	entecavir FDA Link 08/2012 - 01/2009
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2012 - 02/2005
3	lipoteichoic acidIBA 01/2011 - 02/2008
2	Hemostatics (Antihemorrhagics)IBA 02/2022 - 10/2017
2	Opioid Analgesics (Opioids)IBA 01/2022 - 04/2016
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2016
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020 - 12/2017
2	Etomidate FDA LinkGeneric 11/2019 - 05/2018
2	Propofol (Diprivan)FDA LinkGeneric 11/2019 - 05/2018
2	Oxygen (Dioxygen)IBA 11/2019 - 04/2016
2	Messenger RNA (mRNA)IBA 10/2019 - 02/2015
2	InterleukinsIBA 10/2019 - 04/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 01/2018
2	LigandsIBA 01/2018 - 04/2012
2	MicroRNAs (MicroRNA)IBA 01/2018 - 02/2015
2	CollagenIBA 10/2017 - 04/2016
2	Analgesics (Analgesic Drugs)IBA 01/2017 - 04/2016
2	IronIBA 01/2016 - 02/2012
2	protoporphyrin IXIBA 02/2015 - 06/2013
2	CateninsIBA 02/2014 - 01/2014
2	PorphyrinsIBA 06/2013 - 02/2012
2	ginsenoside F2IBA 08/2012 - 01/2012
2	lipoarabinomannan (LAM)IBA 08/2012 - 11/2010
2	Angiotensin Receptor AntagonistsIBA 08/2011 - 06/2011
2	adefovir dipivoxil (Hepsera)FDA Link 01/2010 - 01/2009
1	PowdersIBA 02/2022
1	AristaIBA 02/2022
1	Polysaccharides (Glycans)IBA 02/2022
1	Sirtuin 3IBA 01/2022
1	ruxolitinibIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	BismuthIBA 01/2022
1	Proton Pump InhibitorsIBA 10/2021
1	AcidsIBA 10/2021
1	Iodine-131IBA 01/2021
1	nelarabine (506U78)FDA Link 01/2021

Therapy/Procedure

14	Therapeutics 02/2022 - 02/2005
7	Drug Therapy (Chemotherapy) 08/2021 - 07/2012
4	Anesthesia 01/2020 - 02/2011
2	Pancreatectomy 06/2021 - 05/2003
2	Stem Cell Transplantation 05/2021 - 01/2021
2	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2020 - 01/2017
2	Aftercare (After-Treatment) 06/2016 - 06/2011
1	Oral Administration 03/2022
1	Radiotherapy 01/2022
1	Pancreaticoduodenectomy 12/2021
1	Segmental Mastectomy (Lumpectomy) 09/2021